# FOUNDAYO

NDC: 0002-4503
Generic name: orforglipron
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260401

FDA application: NDA220934

## Active ingredients

- ORFORGLIPRON CALCIUM: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-4503"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-4503
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62